Bar Harbor Wealth Management Eli Lilly & CO Transaction History

Bar Harbor Wealth Management

$1.55 Billion
Q3 2024

A detailed history of Bar Harbor Wealth Management transactions in Eli Lilly & CO stock. As of the latest transaction made, Bar Harbor Wealth Management holds 77,288 shares of LLY stock, worth $57.8 Million. This represents 4.41% of its overall portfolio holdings.

Number of Shares

77,288

Previous 77,997 0.91%

Holding current value

$57.8 Million

Previous $70.6 Million 3.04%

% of portfolio

4.41%

Previous 4.77%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 16, 2024	SELL	$772.14 - $960.02 $547,447 - $680,654	-709 Reduced 0.91%	77,288 $68.5 Million
Q2 2024 Jul 17, 2024	SELL	$724.87 - $909.04 $109,455 - $137,265	-151 Reduced 0.19%	77,997 $70.6 Million
Q1 2024 Apr 23, 2024	SELL	$592.2 - $792.28 $423,423 - $566,480	-715 Reduced 0.91%	78,148 $60.8 Million
Q4 2023 Jan 17, 2024	SELL	$525.19 - $619.13 $366,057 - $431,533	-697 Reduced 0.88%	78,863 $46 Million
Q3 2023 Nov 28, 2023	SELL	$434.7 - $599.3 $412,965 - $569,335	-950 Reduced 1.18%	79,560 $42.7 Million
Q2 2023 Aug 09, 2023	SELL	$350.74 - $468.98 $129,773 - $173,522	-370 Reduced 0.46%	80,510 $37.8 Million
Q1 2023 Apr 24, 2023	SELL	$310.63 - $364.82 $68,649 - $80,625	-221 Reduced 0.27%	80,880 $27.8 Million
Q4 2022 Jun 09, 2023	BUY	$321.55 - $374.67 $71,062 - $82,802	221 Added 0.27%	81,101 $29.7 Million
Q4 2022 Jan 19, 2023	SELL	$321.55 - $374.67 $8,681 - $10,116	-27 Reduced 0.03%	81,101 $29.7 Million
Q3 2022 Oct 24, 2022	SELL	$296.48 - $337.87 $162,471 - $185,152	-548 Reduced 0.67%	81,128 $26.2 Million
Q2 2022 Aug 12, 2022	BUY	$278.73 - $327.27 $626,027 - $735,048	2,246 Added 2.83%	81,676 $26.5 Million
Q1 2022 Apr 14, 2022	SELL	$234.69 - $291.66 $144,569 - $179,662	-616 Reduced 0.77%	79,430 $22.7 Million
Q4 2021 Jan 28, 2022	SELL	$224.85 - $279.04 $833,069 - $1.03 Million	-3,705 Reduced 4.42%	80,046 $22.1 Million
Q3 2021 Nov 15, 2021	SELL	$221.6 - $272.71 $114,567 - $140,991	-517 Reduced 0.61%	83,751 $19.4 Million
Q2 2021 Aug 11, 2021	SELL	$180.55 - $233.54 $83,053 - $107,428	-460 Reduced 0.54%	84,268 $19.3 Million
Q1 2021 May 06, 2021	SELL	$164.32 - $212.72 $173,521 - $224,632	-1,056 Reduced 1.23%	84,728 $15.8 Million
Q4 2020 Feb 09, 2021	BUY	$130.46 - $172.63 $6,523 - $8,631	50 Added 0.06%	85,784 $14.5 Million
Q3 2020 Nov 02, 2020	SELL	$146.22 - $169.13 $81,152 - $93,867	-555 Reduced 0.64%	85,734 $12.7 Million
Q2 2020 Aug 04, 2020	SELL	$136.42 - $164.18 $350,462 - $421,778	-2,569 Reduced 2.89%	86,289 $14.2 Million
Q1 2020 May 14, 2020	SELL	$119.05 - $147.35 $94,168 - $116,553	-791 Reduced 0.88%	88,858 $12.3 Million
Q4 2019 Feb 11, 2020	SELL	$106.92 - $132.43 $199,191 - $246,717	-1,863 Reduced 2.04%	89,649 $11.8 Million
Q3 2019 Nov 07, 2019	SELL	$106.79 - $116.16 $28,833 - $31,363	-270 Reduced 0.29%	91,512 $10.2 Million
Q2 2019 Aug 01, 2019	BUY	$110.79 - $129.32 $56,170 - $65,565	507 Added 0.56%	91,782 $10.2 Million
Q1 2019 May 10, 2019	SELL	$111.31 - $131.02 $8,236 - $9,695	-74 Reduced 0.08%	91,275 $11.8 Million
Q4 2018 Feb 13, 2019	SELL	$105.9 - $118.64 $39,183 - $43,896	-370 Reduced 0.4%	91,349 $10.6 Million
Q3 2018 Nov 14, 2018	SELL	$85.86 - $107.31 $41,813 - $52,259	-487 Reduced 0.53%	91,719 $9.84 Million
Q2 2018 Aug 10, 2018	SELL	$75.7 - $86.88 $23,315 - $26,759	-308 Reduced 0.33%	92,206 $7.87 Million
Q1 2018 Apr 06, 2018	SELL	$74.21 - $87.6 $51,204 - $60,443	-690 Reduced 0.74%	92,514 $7.16 Million
Q4 2017 Jan 17, 2018	SELL	$81.94 - $87.89 $41,789 - $44,823	-510 Reduced 0.54%	93,204 $7.87 Million
Q3 2017 Oct 11, 2017	BUY	$77.07 - $85.54 $7.22 Million - $8.02 Million	93,714	93,714 $8.02 Million

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bar Harbor Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Bar Harbor Wealth Management with notifications on news.

Account

Bar Harbor Wealth Management Eli Lilly & CO Transaction History